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On the surface of the cornea, cells infected with FHV­1 are green
and the nuclei are blue. When the cornea is treated with the antiviral
drug raltegravir, the number of virus­infected green cells declines
significantly.
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Model helps identify drugs to treat cat eye infections
By Merry R. Buckley
It’s a problem veterinarians see all
the time, but there are few
treatments. Feline herpes virus 1
(FHV-1) is a frequent cause of eye
infections in cats, but the drugs
available to treat these infections
must be applied multiple times a
day and there is scant scientic
evidence to support their use.
Now scientists at the Baker Institute
for Animal Health at Cornell’s
College of Veterinary Medicine
have developed a model system
that can be used to test drugs for
treating these eye infections, and
early results have pointed to a new
drug for treating FHV-1 that will
soon head to clinical trials. The
work is reported in the Journal of
General Virology in June.
“Herpes-induced cornea infections
are a big problem in cats,” says Dr. Gerlinde Van de Walle, who led the study. Cats infected with
FHV-1 will blink continuously, squint and have a teary, sore-looking eye or eyes. “If not treated,
FHV-1 infection can eventually lead to blindness,” she says.
“We wanted to develop a model system that could predict whether an antiviral drug would work
against FHV-1 in cats,” says Van de Walle. They were also searching for an easy way to identify
drugs that could be given only once every 24 hours, because, as vets and many cat owners know,
giving medication to a cat multiple times a day can be a di cult, painful thing to accomplish.
Smearing ointment in a cat’s eyes might be easy the rst and second time, but once the cat
learns what you’re up to with that little tube, she will most likely hide or ght.
Van de Walle and her team used tissues donated from cats that died of causes other than eye
disease. The outer clear layer of the eye, called the cornea, is shaped like a contact lens but has
the consistency of Jell-O. To maintain the natural, dome-shaped structure of these corneas
under laboratory conditions, the team gently lled them with agarose, waited for the agarose to
rm up, then turned them over and kept them in a liquid medium. The model better resembles
what happens in the eyes of a cat compared with using a single layer of cells in a dish and can,
therefore, better predict what to expect in the animal.
To use these petri plate corneas as a model of FHV-1 infection, they applied the virus to some of
the corneas and left others uninfected. They then tested the e񼰂ectiveness of two drugs that are
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used for topical treatment of FHV-1 eye infections in cats: cidofovir, which is frequently used in
the clinic, and acyclovir, which has shown promise when given frequently. Both drugs cleared
the infection when applied every 12 hours, but cidofovir was more e񼰂ective.
Taking it a step further, Van de Walle and her team used the model system to identify another
drug for treating FHV-1 infections. The antiretroviral drug raltegravir is commonly used in
humans to treat HIV infections, and although some reports indicated it could be e񼰂ective against
human herpes viruses, it had never been used to treat FHV-1 in cats before.
“We found that it is very e񼰂ective against FHV-1. It even worked when we applied the drug only
once every 24 hours,” says Van de Walle. This means raltegravir could be just as e cient as the
other drugs available for treating FHV-1 infections, but would only have to be administered once
daily. Van de Walle says she hopes eventually to see the drug tested in a well-controlled clinical
trial.
The research was supported by the Cornell Feline Health Center.
Merry R. Buckley is education and outreach program manager for the Baker Institute for Animal
Health.
